About: Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review
Creator	Muslin, Claire María, Ana Gómez-Barreno, Lenin Ortiz-Prado, Esteban Simbaña-Rivera, Katherine Barba-Ostria, Carlos Cevallos-Robalino, Doménica Gadian, Naomi Guaman, Linda Jaramillo, Gómez Kyriakidis, Nikolaos Rubio-Neira, Mario Sanches-Sanmiguel, Hugo Unigarro, Luis Zalakeviciute, Rasa
Source	Elsevier; Medline; PMC
abstract	Abstract Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least seven coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20th May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19).
has issue date	2020-05-30(xsd:dateTime)
bibo:doi	10.1016/j.diagmicrobio.2020.115094
bibo:pmid	32623267
has license	els-covid
sha1sum (hex)	e307edec1477a8fe1ae108b02f80a7a50065a855
schema:url	https://doi.org/10.1016/j.diagmicrobio.2020.115094
resource representing a document's title	Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review
has PubMed Central identifier	PMC7260568
has PubMed identifier	32623267
schema:publication	Diagn Microbiol Infect Dis
resource representing a document's body	covid:e307edec1477a8fe1ae108b02f80a7a50065a855#body_text
is schema:about of	named entity 'virus' named entity 'negative-strand' named entity 'asymptomatic' named entity 'SARS-CoV' named entity 'tumor' named entity 'vaccines' named entity 'ARDS' named entity 'phase 3' named entity 'proinflammatory cytokine' named entity 'protein' named entity 'MERS-CoV' named entity 'lung' named entity 'symptom' named entity 'low-affinity' named entity 'COVID' named entity 'ARDS' named entity 'Procalcitonin' named entity 'comorbidities' named entity 'primers' named entity 'animal models' named entity 'neutrophil' named entity 'nausea' named entity '229E' named entity 'passive immunity' named entity 'COVID' named entity 'vaccine' named entity 'angiotensin' named entity 'Procalcitonin' named entity 'Italy' named entity 'genome sequences' named entity 'SARS-CoV' named entity 'coronavirus' named entity 'Loop-mediated isothermal amplification' named entity 'supplemental oxygen' named entity 'SARS-CoV' named entity 'cytokines' named entity 'urinary output' named entity 'stroke volume' named entity 'precipitation' named entity 'developed countries' named entity 'randomized controlled trial' named entity 'SARS' named entity 'COVID' named entity 'ligand binding' named entity 'ARDS' named entity 'TLRs' named entity 'mRNAs' named entity 'vaccine' named entity 'antigen presenting cells' named entity 'chemical treatment' named entity 'IgG' named entity 'pathogen' named entity 'vaccines' named entity 'IgG' named entity 'non-specific' named entity 'chronically ill' named entity 'Wuhan' named entity 'general population' named entity 'comorbidities' named entity 'TNF-α' named entity 'Dyspnea' named entity 'respiratory complications' named entity 'ultraviolet' named entity 'SARS-CoV-2' named entity 'China' named entity 'SARS-CoV-2' named entity 'asymptomatic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software